| Diagnosis, S taging, and M anagement of H epatocellular C arcinoma: 2018 P ractice G uidance by the A merican A ssociation for the S tudy of L iver D iseases JA Marrero, LM Kulik, CB Sirlin, AX Zhu, RS Finn, MM Abecassis, ... Hepatology 68 (2), 723-750, 2018 | 4381 | 2018 |
| AASLD guidelines for the treatment of hepatocellular carcinoma JK Heimbach, LM Kulik, RS Finn, CB Sirlin, MM Abecassis, LR Roberts, ... Hepatology 67 (1), 358-380, 2018 | 4084 | 2018 |
| Epidemiology and management of hepatocellular carcinoma L Kulik, HB El-Serag Gastroenterology 156 (2), 477-491. e1, 2019 | 1623 | 2019 |
| Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes R Salem, RJ Lewandowski, MF Mulcahy, A Riaz, RK Ryu, S Ibrahim, ... Gastroenterology 138 (1), 52-64, 2010 | 1236 | 2010 |
| Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors KM Olthoff, L Kulik, B Samstein, M Kaminski, M Abecassis, J Emond, ... Liver transplantation 16 (8), 943-949, 2010 | 1215 | 2010 |
| Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma R Salem, RJ Lewandowski, L Kulik, E Wang, A Riaz, RK Ryu, KT Sato, ... Gastroenterology 140 (2), 497-507. e2, 2011 | 767 | 2011 |
| Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis LM Kulik, BI Carr, MF Mulcahy, RJ Lewandowski, B Atassi, RK Ryu, ... Hepatology 47 (1), 71-81, 2008 | 746 | 2008 |
| Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma JM Llovet, T De Baere, L Kulik, PK Haber, TF Greten, T Meyer, R Lencioni Nature reviews Gastroenterology & hepatology 18 (5), 293-313, 2021 | 721 | 2021 |
| AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma AG Singal, JM Llovet, M Yarchoan, N Mehta, JK Heimbach, LA Dawson, ... Hepatology 78 (6), 1922-1965, 2023 | 710 | 2023 |
| Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma R Salem, AC Gordon, S Mouli, R Hickey, J Kallini, A Gabr, MF Mulcahy, ... Gastroenterology 151 (6), 1155-1163. e2, 2016 | 685 | 2016 |
| A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization RJ Lewandowski, LM Kulik, A Riaz, S Senthilnathan, MF Mulcahy, ... American journal of transplantation 9 (8), 1920-1928, 2009 | 681 | 2009 |
| Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers SD Murad, WR Kim, DM Harnois, DD Douglas, J Burton, LM Kulik, ... Gastroenterology 143 (1), 88-98. e3, 2012 | 643 | 2012 |
| Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation LM Kulik, B Atassi, L Van Holsbeeck, T Souman, RJ Lewandowski, ... Journal of surgical oncology 94 (7), 572-586, 2006 | 397 | 2006 |
| Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review A Riaz, RJ Lewandowski, LM Kulik, MF Mulcahy, KT Sato, RK Ryu, ... Journal of Vascular and Interventional Radiology 20 (9), 1121-1130, 2009 | 359 | 2009 |
| Radioembolization with 90Y Microspheres: Angiographic and Technical Considerations RJ Lewandowski, KT Sato, B Atassi, RK Ryu, AA Nemcek, L Kulik, ... Cardiovascular and interventional radiology 30, 571-592, 2007 | 317 | 2007 |
| Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology‐pathology correlation and survival of radiation segmentectomy M Vouche, A Habib, TJ Ward, E Kim, L Kulik, D Ganger, M Mulcahy, ... Hepatology 60 (1), 192-201, 2014 | 309 | 2014 |
| Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma VR Mas, DG Maluf, KJ Archer, K Yanek, X Kong, L Kulik, CE Freise, ... Molecular medicine 15, 85-94, 2009 | 308 | 2009 |
| Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation RA Fisher, LM Kulik, CE Freise, ASF Lok, TH Shearon, RS Brown Jr, ... American journal of transplantation 7 (6), 1601-1608, 2007 | 306 | 2007 |
| Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: a systematic review and meta‐analysis L Kulik, JK Heimbach, F Zaiem, J Almasri, LJ Prokop, Z Wang, MH Murad, ... Hepatology 67 (1), 381-400, 2018 | 302 | 2018 |
| Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection M Vouche, RJ Lewandowski, R Atassi, K Memon, VL Gates, RK Ryu, ... Journal of hepatology 59 (5), 1029-1036, 2013 | 287 | 2013 |
